Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-779
Closed -$223K 238
2023
Q3
$223K Hold
779
0.04% 216
2023
Q2
$219K Buy
+779
New +$203K 0.04% 221
2017
Q1
Sell
-14,640
Closed -$1.95M 240
2016
Q4
$1.95M Hold
14,640
0.6% 50
2016
Q3
$1.91M Sell
14,640
-240
-2% -$31.3K 0.78% 19
2016
Q2
$1.9M Sell
14,880
-240
-2% -$31.7K 0.74% 32
2016
Q1
$2.08M Sell
15,120
-1,525
-9% -$209K 0.39% 56
2015
Q4
$2.44M Hold
16,645
0.42% 80
2015
Q3
$2.25M Sell
16,645
-6,000
-26% -$871K 0.46% 67
2015
Q2
$3.67M Hold
22,645
0.67% 47
2015
Q1
$2.93M Hold
22,645
0.54% 58
2014
Q4
$2.33M Hold
22,645
0.44% 72
2014
Q3
$2.05M Hold
22,645
0.4% 84
2014
Q2
$2.08M Hold
22,645
0.38% 85
2014
Q1
$1.9M Buy
+22,645
New +$1.86M 0.33% 99

Other funds holding CI

Stanley-Laman Group's CI Position: Q4 2023 in Review

Stanley-Laman Group sold out of Cigna (CI) in Q4 2023, closing a stake of 779 shares — an estimated $223K sold.

Stanley-Laman Group first reported a position in CI in Q1 2014 and held it in 14 quarters. The position peaked at $3.67M in Q2 2015. 1,627 funds tracked by Wall St. Rank hold CI as of Q4 2023.

  • Stanley-Laman Group reported no remaining Cigna position as of Q4 2023 after selling out during the quarter.
  • Stanley-Laman Group sold 779 Cigna shares in Q4 2023, an estimated $223K.
  • Stanley-Laman Group first reported a position in Cigna in Q1 2014 and held it in 14 quarters.
  • Stanley-Laman Group's Cigna position peaked at $3.67M in Q2 2015.
  • 1,627 funds tracked by Wall St. Rank held Cigna as of Q4 2023.

Based on Stanley-Laman Group's 13F filing for Q4 2023, filed 2 Feb 2024.